Analyst Consensus ?
ConsensusBuy34 ratings
Bullish2573.5%
Neutral823.5%
Bearish13.0%
FN2 Earnings Intelligence
International Flavors & Fragrances Inc. complete analyst coverage
International Flavors & Fragrances Inc. (IFF) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$83.61Previous close
$67Low
$98.56Average
$170High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Aug 7, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Benchmark | Buy | Buy | Maintain | Aug 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 1, 2026 |
| Argus Research | Buy | Buy | Maintain | Jun 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 24, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Feb 17, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 13, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 14, 2025 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Sep 8, 2025 |
| Tigress Financial | Buy | Buy | Maintain | Aug 26, 2025 |
| Baird | Outperform | Outperform | Maintain | May 8, 2025 |
| Stifel | Buy | Buy | Maintain | Apr 10, 2025 |
| Vertical Research | Buy | Hold | Upgrade | Nov 7, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 20, 2024 |
| Jefferies | Buy | Hold | Upgrade | Jan 12, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Aug 10, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 8, 2023 |
| Societe Generale | Buy | Buy | Maintain | Nov 9, 2022 |
| Berenberg | Hold | Buy | Downgrade | Aug 24, 2022 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Jan 12, 2021 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 10, 2020 |
| CFRA | Buy | Buy | Maintain | May 13, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Dec 16, 2019 |
| Citi | Buy | Neutral | Upgrade | Nov 22, 2019 |
| KeyBanc | Overweight | Overweight | Maintain | Aug 8, 2019 |
| Raymond James | Underperform | Market Perform | Downgrade | Nov 16, 2018 |
| Argus | Hold | Buy | Downgrade | Jun 8, 2018 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Jan 17, 2018 |
| Gabelli & Co. | Hold | Buy | Downgrade | Aug 10, 2016 |
| Edward Jones | Buy | Buy | Maintain | Oct 1, 2015 |
| Janney Capital | Buy | Buy | Maintain | Nov 25, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $83.61. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $96 | $84.55 | +14.8% | Aug 7, 2026 |
| Robert W. Baird | Ghansham Panjabi | $100 | $85.61 | +19.6% | Aug 6, 2026 |
| UBS | Joshua Spector | $91 | $85.92 | +8.8% | Aug 6, 2026 |
| Oppenheimer | Analyst unavailable | $95 | $85.87 | +13.6% | Aug 6, 2026 |
| Vertical Research | Analyst unavailable | $93 | $85.63 | +11.2% | Aug 6, 2026 |
| Morgan Stanley | Analyst unavailable | $95 | $80.02 | +13.6% | Jul 1, 2026 |
| Oppenheimer | Analyst unavailable | $90 | $82.93 | +7.6% | May 7, 2026 |
| Barclays | Lauren Lieberman | $90 | $82.93 | +7.6% | May 7, 2026 |
| Barclays | Lauren Lieberman | $80 | $72.1 | -4.3% | Apr 14, 2026 |
| UBS | Joshua Spector | $75 | $73.13 | -10.3% | Apr 9, 2026 |
| Deutsche Bank | Analyst unavailable | $95 | $82.18 | +13.6% | Feb 17, 2026 |
| Mizuho Securities | Analyst unavailable | $92 | $83 | +10.0% | Feb 17, 2026 |
| Morgan Stanley | Lisa De Neve | $93 | $82.43 | +11.2% | Feb 13, 2026 |
| Robert W. Baird | Analyst unavailable | $90 | $82.44 | +7.6% | Feb 13, 2026 |
| UBS | Joshua Spector | $85 | $81.72 | +1.7% | Feb 13, 2026 |
| Oppenheimer | Analyst unavailable | $97 | $81.14 | +16.0% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $91 | $81.5 | +8.8% | Feb 13, 2026 |
| Mizuho Securities | John Roberts | $85 | $76.97 | +1.7% | Feb 12, 2026 |
| Argus Research | Analyst unavailable | $80 | $72.78 | -4.3% | Jan 22, 2026 |
| Barclays | Lauren Lieberman | $78 | $70.78 | -6.7% | Jan 16, 2026 |
| UBS | Analyst unavailable | $71 | $69.23 | -15.1% | Jan 12, 2026 |
| UBS | Joshua Spector | $66 | $61.6 | -21.1% | Oct 6, 2025 |
| Mizuho Securities | Analyst unavailable | $75 | $61.51 | -10.3% | Oct 3, 2025 |
| Oppenheimer | Kristen Owen | $89 | $64.23 | +6.4% | Aug 7, 2025 |
| Barclays | Lauren Lieberman | $82 | $78.18 | -1.9% | Mar 27, 2025 |
| Argus Research | Alexandra Yates | $93 | $82.56 | +11.2% | Jan 7, 2025 |
| Morgan Stanley | Lisa De Neve | $110 | $91.21 | +31.6% | Nov 11, 2024 |
| Stifel Nicolaus | Mark Astachan | $121 | $103.88 | +44.7% | Oct 24, 2024 |
| Oppenheimer | Kristen Owen | $117 | $101.28 | +39.9% | Sep 11, 2024 |
| Mizuho Securities | John Roberts | $120 | $103.99 | +43.5% | Sep 3, 2024 |
| Stifel Nicolaus | Mark Astrachan | $115 | $95.67 | +37.5% | Jul 22, 2024 |
| UBS | Joshua Spector | $100 | $96.64 | +19.6% | Jul 9, 2024 |
| Jefferies | Laurence Alexander | $111 | $98.14 | +32.8% | Jun 24, 2024 |
| Oppenheimer | Kristen Owen | $116 | $97.9 | +38.7% | Jun 6, 2024 |
| Morgan Stanley | Lisa De Neve | $100 | $98.1 | +19.6% | May 21, 2024 |
| Jefferies | Laurence Alexander | $110 | $97.23 | +31.6% | May 8, 2024 |
| Mizuho Securities | John Roberts | $98 | $88.66 | +17.2% | May 7, 2024 |
| Barclays | Lauren Lieberman | $75 | $86.57 | -10.3% | Apr 12, 2024 |
| Wells Fargo | Michael Sison | $100 | $85.5 | +19.6% | Apr 4, 2024 |
| Deutsche Bank | David Begleiter | $100 | $83.92 | +19.6% | Mar 20, 2024 |
| Stifel Nicolaus | Mark Astachan | $85 | $83.05 | +1.7% | Mar 19, 2024 |
| Morgan Stanley | Lisa De Neve | $90 | $79.76 | +7.6% | Jan 22, 2024 |
| Jefferies | Laurence Alexander | $112 | $80.25 | +34.0% | Jan 12, 2024 |
| J.P. Morgan | Jeffrey Zekauskas | $67 | $80.97 | -19.9% | Jan 2, 2024 |
| Argus Research | John Eade | $85 | $75.67 | +1.7% | Nov 28, 2023 |
| Stifel Nicolaus | Mark Astrachan | $81 | $68.09 | -3.1% | Sep 18, 2023 |
| Stifel Nicolaus | Mark Astrachan | $160 | $133.19 | +91.4% | Jan 25, 2022 |
| Jefferies | Laurence Alexander | $180 | $144.97 | +115.3% | Jan 13, 2022 |
| Citigroup | PJ Juvekar | $147 | $136.21 | +75.8% | May 20, 2021 |
| Societe Generale | Thomas Swoboda | $170 | $138.69 | +103.3% | May 19, 2021 |
| Morgan Stanley | Lisa De Neve | $160 | $137.3 | +91.4% | Apr 12, 2021 |
Track every rating change on IFF the moment it posts. Free to start.
Start free